Literature DB >> 11780313

The relationship between plasma apolipoprotein A-IV levels and coronary heart disease.

M W Manpuya1, J Guo, Y Zhao.   

Abstract

OBJECTIVE: To evaluate the relationship between plasma apoA-IV levels and coronary atherosclerosis and to explore its relation to other risk factors.
METHODS: Using ELISA techniques, plasma apoA-IV levels were quantified in 181 patients who underwent coronary angiography (CAG). Patients were divided according to their coronary status into a coronary heart disease (CHD) group (stenotic lesion on CAG, n = 118) and a control group (normal CAG, n = 63). The severity of atherosclerosis was assessed by stenosis scoring of the different lesions. Other parameters, including apoA-I, apoB, Lp(a), HDL-C, LDL-C, TG, and TC, were measured as well. Univariate, logistic regression analyses were used to define the relationship between coronary atherosclerosis and plasma apoA-IV levels.
RESULTS: When compared with the control group, plasma apoA-IV levels were found to be lower in the CHD group. There was a weak negative correlation between plasma apoA-IV levels and the severity of coronary atherosclerosis. ApoA-IV was found to be a relatively independent risk factor for CHD. We also found a positive correlation between apoA-IV and triglyceride levels.
CONCLUSIONS: ApoA-IV may be important in the prediction of CHD and coronary atherosclerosis severity. It may also play an important role in the metabolism of triglycerides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11780313

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  11 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 2.  Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology.

Authors:  Jaroslav A Hubacek
Journal:  Gene       Date:  2016-08-02       Impact factor: 3.688

Review 3.  HDL in CKD-The Devil Is in the Detail.

Authors:  Florian Kronenberg
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

4.  Age- and sex-associated plasma proteomic changes in growth hormone receptor gene-disrupted mice.

Authors:  Juan Ding; Darlene E Berryman; Adam Jara; John J Kopchick
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-12-07       Impact factor: 6.053

5.  Graded effects of proteinuria on HDL structure in nephrotic rats.

Authors:  Gregory C Shearer; John W Newman; Bruce D Hammock; George A Kaysen
Journal:  J Am Soc Nephrol       Date:  2005-03-23       Impact factor: 10.121

Review 6.  Emerging risk factors and markers of chronic kidney disease progression.

Authors:  Florian Kronenberg
Journal:  Nat Rev Nephrol       Date:  2009-12       Impact factor: 28.314

Review 7.  [Atherosclerosis and uremia: signifance of non-traditional risk factors].

Authors:  Walter H Hörl
Journal:  Wien Klin Wochenschr       Date:  2003-04-30       Impact factor: 1.704

8.  A genome-wide association meta-analysis on apolipoprotein A-IV concentrations.

Authors:  Claudia Lamina; Salome Friedel; Stefan Coassin; Rico Rueedi; Noha A Yousri; Ilkka Seppälä; Christian Gieger; Sebastian Schönherr; Lukas Forer; Gertraud Erhart; Barbara Kollerits; Pedro Marques-Vidal; Janina Ried; Gerard Waeber; Sven Bergmann; Doreen Dähnhardt; Andrea Stöckl; Stefan Kiechl; Olli T Raitakari; Mika Kähönen; Johann Willeit; Ludmilla Kedenko; Bernhard Paulweber; Annette Peters; Thomas Meitinger; Konstantin Strauch; Terho Lehtimäki; Steven C Hunt; Peter Vollenweider; Florian Kronenberg
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

9.  Evaluating the Causal Relation of ApoA-IV with Disease-Related Traits - A Bidirectional Two-sample Mendelian Randomization Study.

Authors:  Salome Mack; Stefan Coassin; Julien Vaucher; Florian Kronenberg; Claudia Lamina
Journal:  Sci Rep       Date:  2017-08-18       Impact factor: 4.379

10.  Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Authors:  Montserrat Baldan-Martin; Juan A Lopez; Nerea Corbacho-Alonso; Paula J Martinez; Elena Rodriguez-Sanchez; Laura Mourino-Alvarez; Tamara Sastre-Oliva; Tatiana Martin-Rojas; Raul Rincón; Eva Calvo; Jesus Vazquez; Fernando Vivanco; Luis R Padial; Gloria Alvarez-Llamas; Gema Ruiz-Hurtado; Luis M Ruilope; Maria G Barderas
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.